Last updated 14 days ago
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
4935 patients around the world
Available in Puerto Rico, Spain, Argentina, United States
Boehringer Ingelheim
2Research sites
4935Patients around the world
This study is for people with
Obesity
Cardiovascular disease
Established cardiovascular disease
Renal disease
Chronic kidney disease
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Ramón Falcón 5206, CABA, Buenos Aireshttps://www.cemedic.com.ar/
SponsorBoehringer Ingelheim
Conditions
Established cardiovascular diseaseChronic kidney disease
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06077864
